Cheng Kevin J, Demir Özlem, Amaro Rommie E
Department of Chemistry & Biochemistry, University of California, San Diego, La Jolla, CA 92093, USA.
National Biomedical Computation Resource, University of California, San Diego, La Jolla, CA 92093, USA.
Genes (Basel). 2017 Jun 20;8(6):166. doi: 10.3390/genes8060166.
African trypanosomiasis occurs in 36 countries in sub-Saharan Africa with 10,000 reported cases annually. No definitive remedy is currently available and if left untreated, the disease becomes fatal. Structural and biochemical studies of trypanosomal terminal uridylyl transferases (TUTases) demonstrated their functional role in extensive uridylate insertion/deletion of RNA. RNA Editing TUTase 1 (TbRET1) is involved in guide RNA 3' end uridylation and maturation, while TbRET2 is responsible for U-insertion at RNA editing sites. Two additional TUTases called TbMEAT1 and TbTUT4 have also been reported to share similar function. TbRET1 and TbRET2 are essential enzymes for the parasite viability making them potential drug targets. For this study, we clustered molecular dynamics (MD) trajectories of four TUTases based on active site shape measured by Pocket Volume Measurer (POVME) program. Among the four TUTases, TbRET1 exhibited the largest average pocket volume, while TbMEAT1's and TbTUT4's active sites displayed the most flexibility. A side pocket was also identified within the active site in all TUTases with TbRET1 having the most pronounced. Our results indicate that TbRET1's larger side pocket can be exploited to achieve selective inhibitor design as FTMap identifies it as a druggable pocket.
非洲锥虫病发生在撒哈拉以南非洲的36个国家,每年报告的病例有10000例。目前尚无确切的治疗方法,如果不治疗,这种疾病会致命。对锥虫末端尿苷酰转移酶(TUTases)的结构和生化研究表明,它们在RNA广泛的尿苷酸插入/缺失中发挥功能作用。RNA编辑TUTase 1(TbRET1)参与引导RNA 3'末端尿苷酸化和成熟,而TbRET2负责在RNA编辑位点插入尿苷。另外两种称为TbMEAT1和TbTUT4的TUTases也被报道具有类似功能。TbRET1和TbRET2是寄生虫生存所必需的酶,使其成为潜在的药物靶点。在本研究中,我们根据通过口袋体积测量仪(POVME)程序测量的活性位点形状,对四种TUTases的分子动力学(MD)轨迹进行了聚类。在这四种TUTases中,TbRET1的平均口袋体积最大,而TbMEAT1和TbTUT4的活性位点表现出最大的灵活性。在所有TUTases的活性位点内还发现了一个侧口袋,其中TbRET1的最为明显。我们的结果表明,TbRET1较大的侧口袋可用于实现选择性抑制剂设计,因为FTMap将其识别为一个可成药口袋。